Provided by Tiger Trade Technology Pte. Ltd.

Abivax S.A.

102.23
-4.4300-4.15%
Post-market: 102.500.2700+0.26%19:48 EDT
Volume:1.89M
Turnover:196.81M
Market Cap:8.90B
PE:-19.60
High:107.16
Open:106.38
Low:101.29
Close:106.66
52wk High:148.83
52wk Low:69.81
Shares:87.05M
Float Shares:76.46M
Volume Ratio:1.50
T/O Rate:2.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.2168
EPS(LYR):-5.6758
ROE:-157.07%
ROA:-44.65%
PB:18.08
PE(LYR):-18.01

Loading ...

Abivax Soars 35% as Positive Phase 3 Maintenance Supplemental Data Drives Accelerated Rebound

Market Focus
·
Jun 30

Abivax price target raised to $110 from $90 at Wedbush

TIPRANKS
·
Jun 30

Analysts Offer Insights on Healthcare Companies: HeartFlow, Inc. (HTFL), Taysha Gene Therapies (TSHA) and Abivax SA Sponsored ADR (ABVX)

TIPRANKS
·
Jun 30

Abivax Sa : Wedbush Raises Target Price to $110 from $90

THOMSON REUTERS
·
Jun 30

Wedbush Raises Price Target on Abivax to $110 From $90, Keeps Neutral Rating

MT Newswires Live
·
Jun 30

Top Premarket Gainers

MT Newswires Live
·
Jun 30

Stocks to Watch: Strategy, Super Micro, Constellation Brands

Dow Jones
·
Jun 30

U.S. Research Roundup- Comcast, Honeywell Aerospace, Qualys

Reuters
·
Jun 30

Movement Alert|Abivax S.A. Rises 27.93% Overnight, Positive Phase 3 Maintenance Data Accelerates Safety Concern Recovery

Market Focus
·
Jun 30

Abivax Reports Positive Phase 3 Maintenance Data for Ulcerative Colitis Drug

MT Newswires Live
·
Jun 30

Movement Alert|Abivax S.A. Rises 21.37% in After-Hours Trading, Safety Controversy Digestion Fuels Rebound Momentum

Market Focus
·
Jun 30

Abivax announces results from ABTECT Maintenance Part 2

TIPRANKS
·
Jun 30

Abivax trading halted, news pending

TIPRANKS
·
Jun 30

NASDAQ Trade Halt Halt News Pending at 04:01 Pm

Reuters
·
Jun 30

European Equities Traded in the US as American Depositary Receipts Decline Friday

MT Newswires Live
·
Jun 26

Movement Alert|Abivax S.A. Rises 5.48% in Regular Trading, Bull-Bear Debate Intensifies Amid Phase 3 Trial Safety Controversy

Market Focus
·
Jun 26

Movement Alert|Abivax S.A. Falls 5.38% in After-Hours Trading, Phase 3 Trial Safety Controversy Continues to Suppress Rebound Momentum

Market Focus
·
Jun 26

Movement Alert|Abivax S.A. Falls 5.62% in Regular Trading, Phase 3 Trial Safety Concerns Continue to Suppress Rebound Momentum

Market Focus
·
Jun 26

Movement Alert|Abivax S.A. Overnight Decline 5.84%, Phase 3 Trial Safety Controversy Continues to Suppress Rebound

Market Focus
·
Jun 25

Movement Alert|Abivax S.A. Falls 5.15% in Regular Trading, Phase 3 Trial Safety Controversy Stalls Recovery Momentum

Market Focus
·
Jun 24